Intercept Pharmaceuticals, Inc.

NORTHERN TRUST CORP

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

383,323

Value ($000)

7,107

Weight

0.0%

2013 Q4 - 2023 Q3 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	7,107	0.0%	383,323	9/30/2023
2023 Q2	8/11/2023	3,065	0.0%	277,107	6/30/2023
2023 Q1	5/15/2023	3,656	0.0%	272,192	3/31/2023
2022 Q4	2/13/2023	3,327	0.0%	268,995	12/31/2022
2022 Q3	11/14/2022	3,460	0.0%	248,015	9/30/2022
2022 Q2	8/12/2022	3,433	0.0%	248,607	6/30/2022
2022 Q1	5/13/2022	4,308	0.0%	264,762	3/31/2022
2021 Q4	2/8/2022	4,531	0.0%	278,147	12/31/2021
2021 Q3	11/15/2021	4,236	0.0%	285,204	9/30/2021
2021 Q2	8/13/2021	5,995	0.0%	300,207	6/30/2021
2021 Q1	5/12/2021	6,609	0.0%	286,341	3/31/2021
2020 Q4	2/11/2021	7,374	0.0%	298,531	12/31/2020
2020 Q3	11/16/2020	12,744	0.0%	307,426	9/30/2020
2020 Q2	8/14/2020	16,374	0.0%	341,767	6/30/2020
2020 Q1	5/14/2020	21,104	0.0%	335,203	3/31/2020
2019 Q4	2/14/2020	41,097	0.0%	331,637	12/31/2019
2014 Q1	5/14/2014	37,955	0.0%	115,091	3/31/2014
2013 Q4	2/21/2014	7,337	0.0%	107,465	12/31/2013